Early Versus Late-Onset Parkinson's Disease: The Role of the Locus Coeruleus

References

• Adolfsson R., Gottfries C. O., Ross B. E., Winblad B. Changes in (he brain catecholamines in patients with dementia of the Alzheimer type. British Journal of Psychiatry 1979; 135: 216–223
   PubMedGoogle Scholar
• Agid Y., Javoy F., Glowinski J. Hyperactivity of remaining dopaminergic neurons after partial destruction of the nigrostriatal dopaminergic system in the rat. Nature 1973; 245: 150–151
   PubMedGoogle Scholar
• Ealvord C., Forno L. S., Kusske J. A., Kaufman R. J., Rhodes J. S., Goetowski C. R. The pathology of Parkinsonism: A comparison of degenerations in cerebral cortex and brain stem. Advances in Neurology 1974; 5: 175–193
   PubMedGoogle Scholar
• Bokobza B., Ruberg M., Scatton M., Javoy-Agid R., Agid Y. 'H-spipcrone binding, dopamine and HVA concentrations in Parkinson's disease and supranuclear palsy. Europena Journal of Pharmacology 1984; 99: 167–175
   PubMedGoogle Scholar
• Bondareff W., Mountjoy C. Q., Roth M. Loss of neurons of origin of the adrenergic projections to cerebral cortex (nucleus locus coerulcus) in senile dementia. Neurology 1982; 32: 164–168
   PubMed Web of Science ®Google Scholar
• Cash R., Dennis T., L'heureux R., Raisman R., Javoy-Agid F., Scatton B. Parkinson's disease and dementia: Norepinephrine and dopamine in locus ceruleus. Neurology 1987; 37: 42–46
   PubMed Web of Science ®Google Scholar
• Diamond B. I., Borison R. L. Enkephalins and nigrostriatal function. Neurology 1978; 28: 1085–1088
   PubMed Web of Science ®Google Scholar
• Garver D. L., Davis J. M. Biogenic amine hypotheses of affective disorders. Life Sciences 1979; 24: 383–394
   PubMed Web of Science ®Google Scholar
• Gaspar P., Gary F. Dementia in idiopathic Parkinson's disease. A neuropathological study of 32 cases. Acta Neuropaihologica (Berlin) 1984; 64: 43–52
   PubMed Web of Science ®Google Scholar
• Gershanik O. S., Leist A. Juvenile onset Parkinson's disease. Advances in Neurology 1986; 45: 213–216
   Google Scholar
• Gibb W. R. G., Less A. J. A comparison of clinical and pathological features of young- and old-onset Parkinson's disease. Neurology 1988; 38: 1402–1406
   PubMed Web of Science ®Google Scholar
• Granerus A. K., Carlsson A., Svanborg A. The aging neuron-Influence on symptomatology and thrapeutic response in Parkinson's syndrome. Advances in neurology, L. J. Poirier, T. L. Sourkes, P. J. Bedard. Raven Press, New York 1979; vol. 24: 327–334
   Google Scholar
• Harik S. I., LaManna J. C., Snyder S., Wetherbee J. R., Rosenthal M. Abnormalities of cerebral oxidative metabolism in animal models of Parkinson disease. Neurology 1982; 32: 382–389
   PubMed Web of Science ®Google Scholar
• Hirano A., Zimmerman II. M. Alzheimer's neurofibrillary changes: A topographic study. Archives of Neurology 1962; 7: 227–242
   PubMedGoogle Scholar
• Hornykiewicz O., Kish S. J. Neurochemical basis of dementia in parkinson's disease. Canadian Journal of Neurological Sciences 1984; II: 185–190, suppl.
   Google Scholar
• Hornykiewicz O. Dopamine (3-hydroxytyramine) and brain functions. Pharamacological Revies 1966; 18: 925–964
   PubMed Web of Science ®Google Scholar
• Iacono R. P., Sandyk R. Opiate antagonists in ischemic stroke. Journal of Neurosurgery 1986; 65: 425–426
   PubMedGoogle Scholar
• Iacono R. P., Sandyk R. Non-cholinergic mechanisms in Alzheimer's disease. Annals of Neurology 1987; 21: 312–313
   PubMedGoogle Scholar
• Jellinger K. Pathology of Parkinsonism. Recent development in Parkinson's disease, S. C. Fahn, D. Marsden, P. Jenner, P. Teychene. Raven Press, New York 1986; 33–66
   Google Scholar
• Kulikowski J. J. Information channels of the senses. Bionics. The nervous system as a control system, R. Gawronsky. Elsevier, Amsterdam 1971; 97–142
   Google Scholar
• Langston J. W., Forno I. S. The hypothalamus in Parkinson disease. Annals of Neurology 1978; 3: 129–133
   PubMed Web of Science ®Google Scholar
• Lieberman A., Dziatolowski M., Kupcrsmith M., Serby M., Goodgold A., Korein J., Goldstein M. Dementia in Parkinson's disease. Annals of Neurology 1979; 6: 355–359
   PubMed Web of Science ®Google Scholar
• Lima B., Nevers G., Nora M. Juvenile Parkinsonism: clincial and metabolic characteristics. Journal of Neurology, Neurosurgery and Psychiatry 1987; 50: 345–348
   PubMedGoogle Scholar
• Ludin S. M., Ludin H. P. Is Pakinson's disease of early onset a separate disease entity?. Journal of Neurology 1989; 236: 203–207
   PubMedGoogle Scholar
• Mann D. M., Yates P. O. The effects of ageing on the pigmented cells of the human locus coeruleus and substantia nigra. Acta Neuropaihologica 1979; 47: 93–98
   PubMedGoogle Scholar
• Mann D. M., Lincoln J., Yates P. O., Stemp J. E., Toper S. Changes in the monoamine containing neurons of the human nervous system in senile dementia. British Journal of Psychiatry 1980; 136: 533–541
   PubMed Web of Science ®Google Scholar
• Mann D. M. A., Yates P. O. Pathological basis for neurotransmitter changes in Parkinson's disease. Neuropathology and Applied Neurobiology 1983; 9: 3–19
   PubMed Web of Science ®Google Scholar
• Mann D. M. A., Yates P. O., Hawkes J. The pathology of the human locus ceruleus. Clinical Neuropathology 1983; 2: 1–7
   PubMed Web of Science ®Google Scholar
• Markianos M., Tripodianakis J. Low plasma dopamine-beta-hydroxylase activity in demented schizophrenics. Biological Psychiatry 1985; 20: 94–119
   PubMed Web of Science ®Google Scholar
• McEntee W. J., Mair R. G. Memory impairment in Korsakoff's psychosis: A correlation with brain noradrenergic activity. Science 1978; 202: 905–907
   PubMed Web of Science ®Google Scholar
• Miyata S., Nagata H., Yamao S., Nakamura S., Kameyama M. Dopamine beta-hydroxylase activities in serum and cerebrospinal fluid of aged and demented patients. Journal of the Neurological Sciences 1984; 63: 403–409
   PubMed Web of Science ®Google Scholar
• Narabayashi H., Kondo T., Nagatsu T., Hayashi A., Suzuki T. DL-threo-3,4,-dihydroxyph-enylserine for freezing symptom in parkinsonism. Advances in neurology, R. G. Hassler, J. F. Christ. Raven Press, New York 1984; vol. 40: 497–502
   Google Scholar
• Narabayashi H., Kondo T., Yokochi F., Nagatsu T. Clincal effects of L-threo-3,4-dihydroxyphenylscrine in cases of Parkinsonism and pure akinesia. Advance in neurology, M. D. Yahr, K. J. Bergmann. Raven Press, New York 1986; vol. 45: 593–602
   Google Scholar
• Quinn N., Critchley P., Marsden C. D. Young onset Parkinson's disease. Movement Disorders 1987; 2: 73–91
   PubMedGoogle Scholar
• Reid W. G. J., Broe G. A., Hely M. A., Morris J. G. L., Williamson P. M., O'Sullivan D. J., Rail D., Genge S., Moss N. G. The neuropsychology of de novo patients with idiopathic Parkinson's disease: The effects of age on onset. International Journal of Neuroscience 1989; 48: 205–217
   PubMed Web of Science ®Google Scholar
• Sandyk R. Enkephalinergic mechanisms in the “compensated” phase of Parkinson's disease. International Journal of Neuroscience 1988; 42: 301–303
   PubMed Web of Science ®Google Scholar
• Sandyk R., Iacono R. P. The relationship of the reticular system to the primary pathoetiology of Parkinson's disease. International Journal of Neuroscience 1988; 42: 297–300
   PubMed Web of Science ®Google Scholar
• Scheff S. W., Bernardo L. S., Cotman C. W. Decrease in adrenergic axon sprouting in the senescent rat. Science 1978; 202: 775–778
   PubMed Web of Science ®Google Scholar
• Schwartz W. J., Sharp F. R., Gunn R. H., Evarts E. V. Lesions of the ascending dopaminergic pathways decrease forebrain glucose uptake. Nature 1976; 261: 155–157
   PubMedGoogle Scholar
• Stern Y., Mayeux R., Cote L. Reaction time and vigilance in Parkinson's disease. Archives of Neurology 1984; 41: 1086–1089
   PubMedGoogle Scholar
• Strahlendorf J. C., Strahlendorf H. K., Barnes C. D. Endorphin mediated inhibition of locus ceruleus neurons. Brain Research 1980; 191: 284–288
   PubMed Web of Science ®Google Scholar
• Tomilson B. E., Irving D., Blessed G. Cell loss in the locus coeruleus in senile dementia of Alzheimer type. Journal of the Neurological sciences 1981; 49: 419–428
   PubMedGoogle Scholar
• Tomonaga M. Neurofibrillary changes observed in the subcortical areas of the aged brain. Special reference on their fine structure. Japanese Journal of Geriatrics 1977; 14: 60–67
   PubMedGoogle Scholar
• Van Dogne P. A.M. The human locus coeruleus in neurology and psychiatry. (Parkinson's, Lewy body, Hallervorden-Spatz, Alzheimer's and Korsakoff's disease, (pre)senile dementia, schizophrenia, affective disorders, psychosis). Progress in Neurobiology 1981; 17: 97–139
   PubMedGoogle Scholar
• Vijayashankar N., Brody H. A quantitative study of the pigmented neurons in the nuclei coeruleus and subcoeruleus in man as related to aging. Journal of Neuropathology and Experimental Neurology 1979; 38: 490–497
   PubMedGoogle Scholar
• Yokochi M., Narabayashi H., Iizuka R., Nagatsu T. Juvenile parkinsonism: some clinical, pharmacological, and neuropathological aspects. Advances in Neurology 1984; 40: 407–413
   PubMedGoogle Scholar
• Zigmond M. J., Acheson A. L., Stachowiak M. K., Strickerm E. M. Neurochemical compensation after nigrostratal bundle injury in an animal model of preclinical Parkinsonism. Archives of Neurology 1984; 41: 856–861
   PubMedGoogle Scholar